Celldex Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Celldex Therapeutics

26/02/2024 12:53

* Celldex Therapeutics Inc  CLDX.OQ  reported a quarterly
adjusted
loss of 83 cents​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -56 cents.  The mean expectation of eight analysts for
the quarter was for a loss of 74 cents per share. Wall Street
expected results to range from -92 cents to -49 cents per share.
    * Revenue fell 83.9% to $259.00 thousand from a year ago;
analysts
expected $842.86 thousand. 
    * Celldex Therapeutics Inc's reported EPS for the quarter
was a
loss of 83 cents​.
    * The company reported a quarterly loss of $43.31 million.
    * Celldex Therapeutics Inc shares had fallen by 4.8% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.7%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Celldex
Therapeutics Inc is $65.00 
This summary was machine generated from LSEG data February 26 at
12:52 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.74          -0.83          Missed
 Sep. 30 2023      -0.68          -0.81          Missed
 Jun. 30 2023      -0.67          -0.65          Beat
 Mar. 31 2023      -0.63          -0.62          Beat